1491 related articles for article (PubMed ID: 26317466)
21. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
23. ISG20 stimulates anti-tumor immunity
Chen Z; Yin M; Jia H; Chen Q; Zhang H
Front Immunol; 2023; 14():1176103. PubMed ID: 37342328
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Stone ML; Chiappinelli KB; Li H; Murphy LM; Travers ME; Topper MJ; Mathios D; Lim M; Shih IM; Wang TL; Hung CF; Bhargava V; Wiehagen KR; Cowley GS; Bachman KE; Strick R; Strissel PL; Baylin SB; Zahnow CA
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10981-E10990. PubMed ID: 29203668
[TBL] [Abstract][Full Text] [Related]
25. Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Wrangle J; Wang W; Koch A; Easwaran H; Mohammad HP; Vendetti F; Vancriekinge W; Demeyer T; Du Z; Parsana P; Rodgers K; Yen RW; Zahnow CA; Taube JM; Brahmer JR; Tykodi SS; Easton K; Carvajal RD; Jones PA; Laird PW; Weisenberger DJ; Tsai S; Juergens RA; Topalian SL; Rudin CM; Brock MV; Pardoll D; Baylin SB
Oncotarget; 2013 Nov; 4(11):2067-79. PubMed ID: 24162015
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma.
Fröhlich A; Loick S; Bawden EG; Fietz S; Dietrich J; Diekmann E; Saavedra G; Fröhlich H; Niebel D; Sirokay J; Zarbl R; Gielen GH; Kristiansen G; Bootz F; Landsberg J; Dietrich D
EBioMedicine; 2020 Feb; 52():102647. PubMed ID: 32028068
[TBL] [Abstract][Full Text] [Related]
27. An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
Schmidt N; Domingues P; Golebiowski F; Patzina C; Tatham MH; Hay RT; Hale BG
Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17399-17408. PubMed ID: 31391303
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts.
Srivastava P; Paluch BE; Matsuzaki J; James SR; Collamat-Lai G; Taverna P; Karpf AR; Griffiths EA
Epigenetics; 2015; 10(3):237-46. PubMed ID: 25793777
[TBL] [Abstract][Full Text] [Related]
29. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.
Benci JL; Johnson LR; Choa R; Xu Y; Qiu J; Zhou Z; Xu B; Ye D; Nathanson KL; June CH; Wherry EJ; Zhang NR; Ishwaran H; Hellmann MD; Wolchok JD; Kambayashi T; Minn AJ
Cell; 2019 Aug; 178(4):933-948.e14. PubMed ID: 31398344
[TBL] [Abstract][Full Text] [Related]
30. Improving cancer immunotherapy with DNA methyltransferase inhibitors.
Saleh MH; Wang L; Goldberg MS
Cancer Immunol Immunother; 2016 Jul; 65(7):787-96. PubMed ID: 26646852
[TBL] [Abstract][Full Text] [Related]
31. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity.
Zhou X; Singh M; Sanz Santos G; Guerlavais V; Carvajal LA; Aivado M; Zhan Y; Oliveira MMS; Westerberg LS; Annis DA; Johnsen JI; Selivanova G
Cancer Discov; 2021 Dec; 11(12):3090-3105. PubMed ID: 34230007
[TBL] [Abstract][Full Text] [Related]
33. Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.
Gatti G; Nuñez NG; Nocera DA; Dejager L; Libert C; Giraudo C; Maccioni M
Eur J Immunol; 2013 Jul; 43(7):1849-61. PubMed ID: 23636788
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer.
Topper MJ; Vaz M; Chiappinelli KB; DeStefano Shields CE; Niknafs N; Yen RC; Wenzel A; Hicks J; Ballew M; Stone M; Tran PT; Zahnow CA; Hellmann MD; Anagnostou V; Strissel PL; Strick R; Velculescu VE; Baylin SB
Cell; 2017 Nov; 171(6):1284-1300.e21. PubMed ID: 29195073
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide effects of DNA methyltransferase inhibitor on gene expression in double-stranded RNA transfected porcine PK15 cells.
Wang X; Ao H; Zhai L; Bai L; He W; Yu Y; Wang C
Genomics; 2014; 103(5-6):371-9. PubMed ID: 24184360
[TBL] [Abstract][Full Text] [Related]
36. TERT activates endogenous retroviruses to promote an immunosuppressive tumour microenvironment.
Mao J; Zhang Q; Wang Y; Zhuang Y; Xu L; Ma X; Guan D; Zhou J; Liu J; Wu X; Liang Q; Wang M; Cong YS
EMBO Rep; 2022 Apr; 23(4):e52984. PubMed ID: 35107856
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppressor Interferon Regulatory Factor 1 selectively blocks expression of endogenous retrovirus.
Stoltz KP; Jondle CN; Pulakanti K; Sylvester PA; Urrutia R; Rao S; Tarakanova VL
Virology; 2019 Jan; 526():52-60. PubMed ID: 30342302
[TBL] [Abstract][Full Text] [Related]
38. The novel human endogenous retrovirus-related gene, psiTPTE22-HERV, is silenced by DNA methylation in cancers.
Liang Q; Ding J; Xu R; Xu Z; Zheng S
Int J Cancer; 2010 Oct; 127(8):1833-43. PubMed ID: 20112338
[TBL] [Abstract][Full Text] [Related]
39. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
[TBL] [Abstract][Full Text] [Related]
40. Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity.
Whitmore MM; DeVeer MJ; Edling A; Oates RK; Simons B; Lindner D; Williams BR
Cancer Res; 2004 Aug; 64(16):5850-60. PubMed ID: 15313929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
